Ivan Bergstein, Chief Executive Officer at STEMLINE THERAPEUTICS INC (STML), sold 70,020 shares at $14.73 ($1.0M) on 2019-08-14, disclosed to the SEC on 2019-08-16.
Open-market sale of $1.0M STML by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.73 | 35,010 | $516K | 50.0% |
| 2 | $14.73 | 35,010 | $516K | 50.0% |
| Total | $14.73 avg | 70,020 | $1.0M | 100% |
| Filing → |
| STML | SELL | 2020-02-28 | $316K | — | Filing → |
| STML | SELL | 2020-01-03 | $987K | — | Filing → |
| STML | SELL | 2019-06-28 | $1.3M | — | Filing → |